UNSPSC 51453104: Morantel pamoate

This classification denotes an antihelminthic agent with the molecular formula C23H16O6.C12H16N2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J33H52K3OO, chemically known as pyrimidine, 1,4,5,6-tetrahydro-1-methyl-2-(2-(3-methyl-2-thienyl)vinyl)-, 4,4'-methylenebis(3-hydroxy-2-naphthoate, (e)-, but more generally known as morantel pamoate, which bears US NIH Compound Identifier 6435816.

European Medicines Agency schedules morantel pamoate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09063MIG. Most nations, for tariff purposes, schedule morantel pamoate under HS 29349990. SMILES: CC1CCSC1/C=C/C2=NCCCN2C.C1CCC2C(C1)CC(C(C2CC3C4CCCCC4CC(C3O)C(=O)O)O)C(=O)O.

UNSPSC 51453104 Morantel pamoate is a Commodity code in the pharmacological products taxonomy, but recent state and local procurement activity under this code shows minimal direct alignment with the nominal product. The code itself denotes a specific anthelmintic pharmaceutical, yet the recent solicitations tagged to it span a broader range of health-related goods—naloxone kits, drug deactivation systems, general medical and first aid supplies, and multi-source generic pharmaceuticals and OTC products. State and local health departments, county community health divisions, fire departments, and cooperative purchasing alliances are the issuing bodies active under this code. The work being solicited ranges from emergency response consumables (respiratory equipment, cardiac monitoring devices, bandaging materials) to direct-to-manufacturer prescription fulfillment programs and generic pharmaceutical distribution contracts. This mismatch suggests either loose categorization by issuing offices or that the code functions as a catch-all for pharmaceutical and medical-supply procurements that do not fit more specific commodities.

The geographic spread spans Florida, Texas, Minnesota (with multi-state participation), and the broader cooperative purchasing landscape. Representative recent opportunities include Seminole County, Florida's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery; the City of Tampa's ITB 26P00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies for the Fire Department Rescue Division, designated as a sheltered market for certified Small Local Business Enterprises with an estimated contract value of $700,000; the Texas Health and Human Services Commission's RFI HHS0017013 (posted April 3, 2026) seeking vendor capabilities for direct-to-manufacturer prescription programs; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers. Activity under this code remains sporadic and broadly scoped rather than concentrated on morantel pamoate itself.